PubMed COVID-19 Clinical Care
2871 - 2880 of 3242 results found
Sustaining Key Services in Federally Qualified Health Centers During the COVID-19 Pandemic
Description
No abstract
Spatial Distribution of SARS-CoV-2 Receptors and Proteases in Testicular Cells
Description
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 RNA has been found in the human testis on occasion, but subgenomic SARS-CoV-2 and infectious SARS-CoV-2 virions have not been found
SS-TBN: A Semi-Supervised Tri-Branch Network for COVID-19 Screening and Lesion Segmentation
Description
Insufficient annotated data and minor lung lesions pose big challenges for computed tomography (CT)-aided automatic COVID-19 diagnosis at an early outbreak stage. To address this issue, we propose a Semi-Supervised Tri-Branch Network (SS-TBN). First
Social and mental health impact of COVID-19 pandemic among health professionals of Gandaki Province, Nepal: A mixed method study
Description
CONCLUSION: This study noted that there is a significant impact of COVID-19 on health professionals in terms of their social and mental health aspects. The social impact experienced by health professionals is an important predictor of their mental
Solid-State Far-Ultraviolet C Light Sources for the Disinfection of Pathogenic Microorganisms Using Graphene Nanostructure Field Emitters
Description
The ongoing global outbreak of coronavirus disease has necessitated the use of ultraviolet (UV) disinfection techniques to reduce viral transmission in public places. The previously used UV wavelength is harmful to the human body, the wavelength
SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection
Description
Several viruses have been shown to modulate the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), the master regulator of redox homeostasis. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the
Share all SARS-CoV-2 data immediately
Description
When the first cases of human infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were reported from Wuhan, China, in December 2019, there was quick agreement across scientific and health communities that understanding the
Safe administration of sotrovimab to a COVID-19 patient with acute phase type 1 diabetes mellitus
Description
Type 1 diabetes mellitus (T1DM) and poor glycemic control are risk factors for severe coronavirus disease 2019 (COVID-19). Sotrovimab can treat mild-to-moderate COVID-19 in patients at a high risk of progression to severe COVID-19. However, its
Short-Term Use Biocontainment Bubbles: Innovative Source Containment of Potentially Infectious SARS-CoV-2 Aerosols
Description
CONCLUSION: From a biorisk management point of view, EHS was able to confine aerosols at their potential source using simple designs and equipment and adhering to the hierarchy of controls. This article demonstrates how a straightforward design
